www.mhlw.go.jp/stf/newpage_23047.html
archives
This URL has 1 public saves. The first save was Apr 9, 2026, 06:02 PM and the latest save was Apr 9, 2026, 06:02 PM.
View recent saves on this domain
Latest saved version
新型コロナウイルス治療薬の特例承認について｜厚生労働省
This is the newest public snapshot for this URL and the best place to start reviewing the page.
Source URL
https://www.mhlw.go.jp/stf/newpage_23047.html
About this page
This page announces the exceptional approval of a COVID-19 treatment drug by Japan's Ministry of Health, Labour and Welfare on December 24, 2021. Under Article 14-3 of the Pharmaceutical Affairs Law, "Lagevrio Capsule 200mg" (generic name: molnupiravir), submitted by MSD Co., Ltd., received special approval for treating SARS-CoV-2 infections. The application was filed on December 3, 2021, with accompanying prescribing information provided separately.
Saved versions
www.mhlw.go.jp/stf/newpage_23047.html web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.